Results 321 to 330 of about 1,321,964 (375)
Some of the next articles are maybe not open access.
Adiponectin in chronic hepatitis C
Clinical Journal of Gastroenterology, 2013White adipose tissue has been increasingly recognized as an important endocrine organ that secretes a number of biologically active adipokines. Adiponectin, one of the major adipokines, possesses anti-inflammatory and insulin-sensitizing properties, and its serum levels typically decline with increasing body weight.
Hitoshi Ikeda +3 more
openaire +3 more sources
2021
Chronic hepatitis C (C-HCV) is caused by an RNA virus, genotype 1a being the most common in the United States. The infection is transmitted by parenteral exposure to contaminated blood products, body fluids, and supplies used in procedures. It becomes chronic in 80% of the patients.
openaire +2 more sources
Chronic hepatitis C (C-HCV) is caused by an RNA virus, genotype 1a being the most common in the United States. The infection is transmitted by parenteral exposure to contaminated blood products, body fluids, and supplies used in procedures. It becomes chronic in 80% of the patients.
openaire +2 more sources
Pathology of Chronic Hepatitis B and Chronic Hepatitis C
Clinics in Liver Disease, 2010Histologic evaluation of the liver is a major component in the medical management and treatment algorithm of patients with chronic hepatitis B (HBV) and chronic hepatitis C (HCV). Liver biopsy in these patients remains the gold standard, and decisions on treatment are often predicated on the degree of damage and stage of fibrosis. This article outlines
openaire +3 more sources
Therapy for chronic hepatitis C
Journal of Physiology-Paris, 2001in Hungary, over the past 5 years more than 900 patients with chronic hepatitis C have been examined for treatment with interferon at 16 major hepatology centres, using unified diagnostic and therapeutical criteria. Authors give an account of their experiences on the clinical features of patients with chronic hepatitis C and report the results of the ...
Pár, Alajos +3 more
openaire +4 more sources
2018
Hepatitis C (HCV) is a common viral infection of the liver. It affects approximately 1.6% of the US population. Screening in the appropriate populations is essential as signs and symptoms of the disease are generally absent. In addition, there are multiple new treatments for HCV which are extremely effective and very well tolerated. In this chapter, we
Stanley Martin Cohen +1 more
openaire +2 more sources
Hepatitis C (HCV) is a common viral infection of the liver. It affects approximately 1.6% of the US population. Screening in the appropriate populations is essential as signs and symptoms of the disease are generally absent. In addition, there are multiple new treatments for HCV which are extremely effective and very well tolerated. In this chapter, we
Stanley Martin Cohen +1 more
openaire +2 more sources
Nitazoxanide for chronic hepatitis C
Cochrane Database of Systematic Reviews, 2014Hepatitis C infection is a disease of the liver caused by the hepatitis C virus. The estimated number of chronically infected people with hepatitis C virus worldwide is about 150 million people. Every year, another three to four million people acquire the infection. Chronic hepatitis C is a leading cause of liver-related mortality and morbidity.
Kristiana Nikolova +3 more
openaire +3 more sources
BMJ clinical evidence, 2007
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions in treatment-naïve people with chronic hepatitis C infection, but ...
Abdul, Mohsen, Suzanne, Norris
openaire +3 more sources
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions in treatment-naïve people with chronic hepatitis C infection, but ...
Abdul, Mohsen, Suzanne, Norris
openaire +3 more sources
Chronic Hepatitis C in Pregnancy
Obstetrics & Gynecology, 2008To estimate outcomes, to determine whether appropriate follow-up was performed for pregnant patients with hepatitis C virus (HCV), and to show that maternal and neonatal complications would be higher in the HCV-positive group.We compared pregnant women from a drug dependence and treatment program who were HCV antibody-positive with those who were HCV ...
Sanjeev Arora +4 more
openaire +2 more sources
The Prevalence of Hepatic Granulomas in Chronic Hepatitis C
Journal of Clinical Gastroenterology, 2004Hepatic granulomas are not usual findings in chronic hepatitis C. A few studies addressing the frequency of hepatic granulomas in chronic hepatitis C reported it as less than 10%. The presence of it has been suggested to predict a favorable response to interferon treatment.
Tozun, N +10 more
openaire +4 more sources
Treatment of chronic hepatitis C
Journal of Hepatology, 1991alpha-Interferon given subcutaneously at doses between 1-3 million units leads to responses in about 50% of patients suffering from chronic hepatitis C. A 24-week treatment is frequently (approx. 50%) followed by relapses reducing the percentage of lasting responders to approx. 20%.
openaire +3 more sources